Wenkai Zhang

Title: Wenkai Zhang: Innovator in Milbemycin Production

Introduction

Wenkai Zhang is a notable inventor based in Huanggang, China. He has made significant contributions to the field of pharmaceutical production, particularly in the synthesis of Milbemycin. With a total of 2 patents to his name, Zhang's work has advanced the efficiency and cost-effectiveness of Milbemycin production.

Latest Patents

Zhang's latest patents include a strain for high-yield production of Milbemycin and a method for synthesizing Milbemycin oxime. The first patent describes an original strain MI-W1-2017001 that undergoes mutation breeding using an atmospheric and room temperature plasma mutation method to create a high-yield strain HZMRYB-5. This innovation improves the fermentation level by approximately 70% compared to the original strain, with further enhancements achieved through process optimization. The second patent outlines a method for synthesizing Milbemycin oxime, which involves an oxidizing reaction and an oximation reaction, resulting in a product yield that surpasses competing products both domestically and internationally.

Career Highlights

Wenkai Zhang is currently employed at Hubei Honch Pharmaceutical Co., Ltd. His work at this company has been pivotal in realizing the industrial production of Milbemycin oxime for the first time in China. His innovative approaches have not only improved production efficiency but also contributed to meeting market demands effectively.

Collaborations

Zhang has collaborated with notable coworkers, including Renwen Zhang and Fubiao He. Their combined efforts have fostered advancements in pharmaceutical research and development.

Conclusion

Wenkai Zhang's contributions to the field of Milbemycin production exemplify the impact of innovation in pharmaceuticals. His patents reflect a commitment to enhancing production methods and meeting industry needs effectively.